Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 5 | 2018 | 371 | 0.810 |
Why?
|
| Hyperthermia, Induced | 3 | 2018 | 53 | 0.740 |
Why?
|
| Ethylenediamines | 2 | 2017 | 5 | 0.730 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2018 | 81 | 0.700 |
Why?
|
| Succinate Dehydrogenase | 1 | 2018 | 13 | 0.620 |
Why?
|
| Hypoxia, Brain | 1 | 2018 | 16 | 0.620 |
Why?
|
| Paraganglioma | 1 | 2018 | 8 | 0.620 |
Why?
|
| Glioblastoma | 2 | 2018 | 219 | 0.600 |
Why?
|
| Aneurysm, Infected | 1 | 2017 | 16 | 0.580 |
Why?
|
| Thiosemicarbazones | 4 | 2020 | 4 | 0.570 |
Why?
|
| Organometallic Compounds | 4 | 2020 | 95 | 0.530 |
Why?
|
| Intracranial Aneurysm | 1 | 2017 | 87 | 0.530 |
Why?
|
| Disease Progression | 1 | 2018 | 1038 | 0.470 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 1070 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 561 | 0.410 |
Why?
|
| Copper Radioisotopes | 3 | 2020 | 5 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 1026 | 0.360 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2020 | 29 | 0.360 |
Why?
|
| Glioma | 3 | 2018 | 140 | 0.340 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2020 | 38 | 0.330 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2020 | 304 | 0.250 |
Why?
|
| Nanoparticles | 2 | 2018 | 254 | 0.240 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1174 | 0.230 |
Why?
|
| Brain | 3 | 2021 | 2176 | 0.230 |
Why?
|
| Cadaver | 2 | 2021 | 136 | 0.220 |
Why?
|
| Radiosurgery | 2 | 2012 | 66 | 0.200 |
Why?
|
| Arachnoid | 1 | 2021 | 1 | 0.190 |
Why?
|
| Hexokinase | 1 | 2020 | 3 | 0.190 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 47 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 1851 | 0.180 |
Why?
|
| Embalming | 1 | 2020 | 1 | 0.180 |
Why?
|
| Cell Survival | 3 | 2018 | 901 | 0.180 |
Why?
|
| Formaldehyde | 1 | 2020 | 48 | 0.180 |
Why?
|
| Pyrazoles | 2 | 2018 | 190 | 0.180 |
Why?
|
| Elasticity | 1 | 2020 | 103 | 0.180 |
Why?
|
| Lymphoma | 1 | 2020 | 116 | 0.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 47 | 0.170 |
Why?
|
| Cerebrum | 1 | 2019 | 20 | 0.170 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 23 | 0.170 |
Why?
|
| Spinal Cord Compression | 1 | 2019 | 23 | 0.170 |
Why?
|
| Eye Movements | 1 | 2019 | 44 | 0.170 |
Why?
|
| Neurosurgery | 1 | 2020 | 42 | 0.170 |
Why?
|
| Erythropoietin | 1 | 2019 | 96 | 0.170 |
Why?
|
| General Surgery | 1 | 2020 | 95 | 0.170 |
Why?
|
| Motor Neurons | 1 | 2019 | 98 | 0.170 |
Why?
|
| Iron Compounds | 1 | 2018 | 6 | 0.160 |
Why?
|
| Femoral Neoplasms | 1 | 2018 | 7 | 0.160 |
Why?
|
| Humans | 19 | 2021 | 68618 | 0.160 |
Why?
|
| Education, Medical | 1 | 2020 | 147 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4848 | 0.150 |
Why?
|
| Protein Subunits | 1 | 2018 | 99 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 742 | 0.150 |
Why?
|
| Motor Cortex | 1 | 2019 | 158 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2018 | 164 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 175 | 0.150 |
Why?
|
| Antidotes | 1 | 2017 | 21 | 0.150 |
Why?
|
| Iron Chelating Agents | 1 | 2017 | 31 | 0.150 |
Why?
|
| Chelating Agents | 1 | 2017 | 47 | 0.150 |
Why?
|
| Skull Base | 1 | 2018 | 72 | 0.150 |
Why?
|
| Deferoxamine | 1 | 2017 | 45 | 0.150 |
Why?
|
| Hemifacial Spasm | 1 | 2017 | 2 | 0.150 |
Why?
|
| Microvascular Decompression Surgery | 1 | 2017 | 2 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2018 | 178 | 0.150 |
Why?
|
| Facial Nerve | 1 | 2017 | 25 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2017 | 7029 | 0.140 |
Why?
|
| Coordination Complexes | 4 | 2020 | 16 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1140 | 0.140 |
Why?
|
| TRPC Cation Channels | 1 | 2016 | 10 | 0.140 |
Why?
|
| Arteries | 1 | 2017 | 108 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2019 | 506 | 0.130 |
Why?
|
| Animals | 10 | 2020 | 20881 | 0.130 |
Why?
|
| Positron-Emission Tomography | 2 | 2014 | 160 | 0.130 |
Why?
|
| Rats | 3 | 2020 | 5300 | 0.130 |
Why?
|
| Iron | 1 | 2017 | 197 | 0.130 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 150 | 0.130 |
Why?
|
| Female | 12 | 2021 | 38074 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 508 | 0.120 |
Why?
|
| Male | 12 | 2021 | 37321 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 62 | 0.110 |
Why?
|
| Methionine | 1 | 2013 | 36 | 0.110 |
Why?
|
| Cell Movement | 1 | 2016 | 630 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 629 | 0.110 |
Why?
|
| Middle Aged | 8 | 2020 | 21147 | 0.110 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2012 | 15 | 0.110 |
Why?
|
| Melanoma | 1 | 2016 | 335 | 0.110 |
Why?
|
| Thallium Radioisotopes | 1 | 2012 | 13 | 0.100 |
Why?
|
| Germinoma | 1 | 2012 | 4 | 0.100 |
Why?
|
| Antineoplastic Protocols | 1 | 2012 | 4 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2550 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 375 | 0.100 |
Why?
|
| Cysts | 1 | 2012 | 70 | 0.100 |
Why?
|
| Brain Stem Neoplasms | 1 | 2012 | 6 | 0.100 |
Why?
|
| Medulla Oblongata | 1 | 2012 | 19 | 0.100 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 137 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2012 | 97 | 0.100 |
Why?
|
| Adult | 7 | 2020 | 21403 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 446 | 0.080 |
Why?
|
| Magnetic Fields | 2 | 2018 | 21 | 0.080 |
Why?
|
| Rabbits | 3 | 2018 | 509 | 0.080 |
Why?
|
| Aged | 6 | 2021 | 14862 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 499 | 0.060 |
Why?
|
| Mice | 1 | 2017 | 8474 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2018 | 1200 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 2093 | 0.060 |
Why?
|
| CD79 Antigens | 1 | 2020 | 5 | 0.050 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2020 | 7 | 0.050 |
Why?
|
| Viral Matrix Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2020 | 15 | 0.050 |
Why?
|
| Glycolysis | 1 | 2020 | 79 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2020 | 50 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2020 | 238 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2020 | 2689 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2018 | 30 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 371 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 567 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 1753 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2020 | 432 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 215 | 0.040 |
Why?
|
| Methotrexate | 1 | 2018 | 91 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 111 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 53 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 236 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 18 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 184 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2017 | 218 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 294 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 131 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 852 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 266 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 532 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 1213 | 0.030 |
Why?
|
| Liver Circulation | 1 | 1995 | 40 | 0.030 |
Why?
|
| Hydrochloric Acid | 1 | 1995 | 19 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 1995 | 12 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 369 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 1995 | 62 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 782 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 232 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 331 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 90 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 92 | 0.030 |
Why?
|
| Neurons | 1 | 2019 | 881 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 2083 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1745 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 114 | 0.030 |
Why?
|
| Craniotomy | 1 | 2012 | 33 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 7277 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 5717 | 0.030 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 4 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 756 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 237 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 239 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1995 | 400 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 239 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 572 | 0.020 |
Why?
|
| Time Factors | 2 | 2016 | 4655 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 392 | 0.020 |
Why?
|
| Lung | 1 | 1995 | 849 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1995 | 1451 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2324 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 8912 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1995 | 25 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1995 | 20 | 0.010 |
Why?
|
| Portal Vein | 1 | 1995 | 46 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1995 | 69 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 168 | 0.010 |
Why?
|
| Endothelium | 1 | 1995 | 98 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 1995 | 110 | 0.010 |
Why?
|
| Epithelium | 1 | 1995 | 172 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1995 | 117 | 0.010 |
Why?
|
| Lung Injury | 1 | 1995 | 38 | 0.010 |
Why?
|
| Head | 1 | 1995 | 59 | 0.010 |
Why?
|
| Posture | 1 | 1995 | 107 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 579 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 618 | 0.010 |
Why?
|
| Swine | 1 | 1995 | 672 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 1040 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1995 | 705 | 0.010 |
Why?
|
| Proteins | 1 | 1995 | 474 | 0.010 |
Why?
|